SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen
IMGN 31.230.0%Feb 26 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gary Mohilner who wrote (5540)1/3/2014 12:35:38 PM
From: rjk01   of 5665
 
thanks for the update, i had a good year again w a mix of biotech, tec and others....70% in total
biotech are at all high so need to be very selective going forward
Keep me posted on your treatment........I dont get to LA much but I will be where ever convenient for you this Dec with a bottle of chocolate liqueur .

I have a large sum in aezs (added at low 1 and sold lately for a gain) but holding still many shares. i remember you were in it during the kerx days (kerx recovered many times over while aezs cont. to tank)........i don't see much downside at this levels and expecting with any catalyst to see 2 again. any thoughts

my bio holding
aezs
ambi
arry
astx (w bought out for 150% gain) 2013
blue
clvs
exel: could be near 20, critical news on phase 3 trial this year.......should have a run prior
snta
arql
gern (had large sum from stem cell days.........as i use that in my practice.........tanked and rose from t dead, could give incy a run for the money)
espr
gnvc
incy
infi
nviv
onxx (w bought out for 100% gain 2013)
plx
pphm
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext